Articles

<b>Background: </b>Tobacco control policies nationwide have contributed to a substantial decline in cigarette and tobacco use, with particularly sharp reductions observed in states such as California that have implemented restrictive bans, strong prevention measures, and high excise taxes. While these policies have led to overall decreases in tobacco use, progress has not necessarily been distributed equally across racial groups. Understanding long-term trends by race is critical for addressing equity gaps in tobacco prevention and control. Evidence suggests that some racialized groups may experience slower or delayed declines, raising concerns about equity in public health gains. <b>Methods: </b>We analyzed data from the California Health Interview Survey (CHIS) spanning 2003–2023. Trends in current smoking were examined separately for non-Latino Black and non-Latino White adults. We also assessed current use of flavored tobacco products, given California’s statewide ban enacted in 2021. Changes were evaluated in both absolute terms (percentage point declines) and relative terms (percent reduction from baseline). <b>Results: </b>Smoking prevalence declined from 17.2% in 2003 to 5.2% in 2023 among White adults and from 19.9% to 9.0% among Black adults. This represents a 12.0 percentage point (69.8%) decline for Whites compared with a 10.9 percentage point (54.8%) decline for Blacks. For flavored tobacco use, prevalence decreased from 8.0% to 4.7% among White adults but only from 11.9% to 10.8% among Black adults. This corresponds to a 3.3 percentage point (41.3%) decline for Whites compared with a 1.1 percentage point (9.2%) decline for Blacks. <b>Conclusions: </b>Although both Black and White adults in California experienced reductions in smoking over the past two decades, White adults showed larger declines in both absolute and relative terms. Disparities were even more pronounced for flavored tobacco use, where declines were minimal among Black adults despite the statewide ban. These findings suggest that Black populations in California may have been left behind by tobacco control progress, especially regarding flavored products. Given the history of targeted marketing by the tobacco industry, the role of flavors in increasing dependence, and reduced access to cessation resources in Black communities, targeted policies and culturally tailored interventions are needed to ensure equitable reductions in tobacco use. Greater attention to flavored tobacco in Black communities may help narrow these disparities and advance California’s tobacco endgame goals.

The synthesis and optimization of Active Pharmaceutical Ingredients (APIs) is fundamental to pharmaceutical drug development, directly influencing drug efficacy, safety, and cost-effectiveness. Over recent years, significant advancements in synthetic methodologies and manufacturing technologies have transformed API production. This manuscript provides an overview of the latest innovations in API synthesis, focusing on key techniques such as green chemistry, continuous flow chemistry, biocatalysis, and automation. Green chemistry principles, including solvent substitution and catalytic reactions, have enhanced sustainability by reducing waste and energy consumption. Continuous flow chemistry offers improved reaction control, scalability, and safety, while biocatalysis provides an eco-friendly alternative for synthesizing complex and chiral APIs. Additionally, the integration of automation and advanced process control using machine learning and real-time monitoring has optimized production efficiency and consistency. The manuscript also discusses the challenges associated with regulatory compliance and quality assurance, highlighting the role of advanced analytical techniques such as HPLC, NMR, and mass spectrometry in ensuring API purity. Looking ahead, personalized medicine and smart manufacturing technologies, including blockchain for traceability, are expected to drive further innovation in API production. This review concludes by emphasizing the need for continued advancements in sustainability, efficiency, and scalability to meet the evolving demands of the pharmaceutical industry, ultimately enabling the development of safer, more effective, and environmentally responsible medicines.

The Internet of Things (IoT) is a network of linked items that can gather, exchange, and act on data thanks to sensors, software, and communication technologies. Networking solutions for large-scale IoT deployments have become a cornerstone in advancing smart applications across industries, cities, and healthcare ecosystems. With billions of connected devices generating vast amounts of data, efficient networking infrastructures are required to ensure seamless communication, reliability, and scalability. IoT architectures, ranging from layered models to advanced cloud–edge integration, offer structured approaches for managing heterogeneous devices and diverse communication protocols. Recent innovations, such as 5G connectivity, Software-defined networking and network function virtualization provide flexibility and programmability, enabling dynamic adaptation to evolving requirements. Edge and fog computing further enhance responsiveness by processing data closer to devices, while AI-driven approaches contribute to intelligent routing, predictive analytics, and self-optimizing network management. Blockchain-based frameworks add transparency and trust, securing data exchange in decentralized environments perspective on how networking continues to transform the capabilities of IoT, setting the foundation for sustainable growth and future adoption across multiple domains.

Machine Learning (ML) and Artificial Intelligence (AI) are having an increasingly transformative impact on all industries and are already used in many mission-critical use cases in production, bringing considerable value. Data engineering, which combines ETL pipelines with other workflows managing data and machine learning operations, is also significantly impacted. The Intelligent Data Engineering and Automation framework offers the groundwork for intelligent automation processes. However, ML/AI are not the only disruptive forces; new Big Data technologies inspired by Web2.0 companies are also reshaping the Internet. Companies having the largest Big Data footprints not only provide applications with a Big Data operational model but also source their competitive advantage from data in the form of AI services and, consequently, impact the cost/performance equilibrium of ETL pipelines. All these technologies and reasons help explain why the traditional ETL pipeline design should adapt to current and emerging technologies and may be enhanced through artificial intelligence.

We investigate and analyze the trends and behaviors in credit card fraud attacks and transactions. First, we perform logical analysis to find hidden patterns and trends, then we leverage game-theoretical models to illustrate the potential strategies of both the attackers and defenders. Next, we demonstrate the strength of industry-scale, privacy-preserving artificial intelligence solutions by presenting the results from our recent exploratory study in this respect. Furthermore, we describe the intrinsic challenges in the context of developing reliable predictive models using more stringent protocols, and hence the need for sector-specific benchmark datasets, and provide potential solutions based on state-of-the-art privacy models. Finally, we conclude the paper by discussing future research lines on the topic, and also the possible real-life implications. The paper underscores the challenges in creating robust AI models for the banking sector. The results also showcase that privacy-preserving AI models can potentially augment sharing capabilities while mitigating liability issues of public-private sector partnerships [1].

Trends in abortion care in the United States are changing quickly, affected by many epidemiological factors as well as a varying political climate. Surgical abortions are the more common method of conducting abortion care. Recent CDC National Surveillance Data has shown an increase in second-trimester abortion, correlating to an increased need for providers experienced in surgical abortions and cervical preparation agents, such as misoprostol, mifepristone, and laminaria. Furthermore, recent studies have shown an increase in long-acting reversible contraceptive options including post-abortion contraceptive use. We hoped to compare the trends in abortion of pregnancy in our low-resource urban environment against the national trends to better understand what demographic factors might influence decision-making. We identified a need for studies on trends in abortions of pregnancy in a low-resource urban setting which can become applicable across similar neighborhoods, some of which might not participate in CDC abortion surveillance reports. Our study shows an increase in dilation and evacuation procedures, correlating with an increase in the use of misoprostol and laminaria for cervical preparation as well as digoxin for induction of fetal demise, both of which would occur at higher frequency in the second trimester. We also found a preference towards no contraception after abortion, which slightly differs from national trends in recent years. Our study aims to evaluate these trends and identify the need for further quality assurance and improvement in this care.